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The HIV-1 Vpu protein induces the proteolysis of CD4 in the endoplasmic reticulum (ER) and enhances the release of
virus particles from the plasma membrane. The two biological activities of HIV-1 Vpu appear to be reconstituted in distinct
membrane compartments of the mammalian cell. We carried out experiments to understand the role of Vpu sequences in
membrane trafficking of the Vpu protein and to gain insights into Vpu-mediated proteolytic reactions. To this end, we
generated CD4/Vpu hybrid proteins and analyzed their biochemical and biological properties in HeLa cells. We show here
that all hybrid proteins are delivered to the plasma membrane undergoing endo-H-resistant modifications in the Golgi
complex. Importantly, a hybrid protein bearing the CD4 extracellular domain and full-length Vpu induced the degradation of
HIV envelope glycoproteins bearing the transmembrane and cytoplasmic domains of CD4 (Vpu-responsive elements, VRE).
Glycoproteins lacking the VRE are stable under these conditions. In addition, a hybrid protein having the extracellular–
transmembrane domains of CD4 and the Vpu cytoplasmic domain was only partially active in inducing the degradation of
Vpu-sensitive proteins. These results suggest that the Vpu transmembrane domain is capable of regulating Vpu activity in
the cell. Mutational studies have further demonstrated that casein kinase-2 phosphorylation is critically important in the
degradation reaction, but does not regulate membrane trafficking of the CD4/Vpu hybrid proteins. We also show that the
CD4 extracellular domain appended to the Vpu protein is protected from degradation while existing in a complex with Vpu-
sensitive ectodomains. Taken together, these studies have revealed that the Vpu protein does not possess sequences that
have the ability to sequester CD4 in the intracellular compartments of mammalian cells and that the Vpu protein tethered
to the CD4 extracellular domain was biologically active in inducing the degradation of VRE-bearing glycoproteins in the ER.
q 1996 Academic Press, Inc.
INTRODUCTION mediated proteolysis in the ER (Schubert and Strebel,
1994; Vincent and Jabbar, 1995), and the virus release
The Vpu protein is unique to HIV-1 and is not encoded function of Vpu was not appreciably affected by the lack
by the majority of HIV-2 and SIV isolates (Cohen et al., of CK-2 phosphorylation (Schubert and Strebel, 1994; Fri-
1988; Strebel et al., 1988; Chen et al., 1993; Bour et al., borg et al., 1995). Importantly, Vpu-mediated proteolytic
1996). This protein appears to have two distinct functions reactions are highly specific in terms of the cellular loca-
in the HIV life cycle: (1) to induce the degradation of CD4 tion and sequence requirements. Several studies have
in the endoplasmic reticulum (ER) and (2) to enhance the identified that the proteolysis of CD4 occurs in the ER
release of virus particles from the plasma membrane. and depends on the presence of both CD4 transmem-
Vpu is a transmembrane phosphoprotein which is coordi- brane and cytoplasmic domains (Chen et al., 1993; Vin-
nately synthesized with HIV-1 gp160 from the same bicis- cent et al., 1993; Lenburg and Landau, 1993; Raja et al.,
tronic mRNA (Schwartz et al., 1990) and in an oligomeric 1994; Buonocore et al., 1994; Willey et al., 1994; Jabbar,
protein (Maldarelli et al., 1993). It contains 27 hydropho- 1995; Yao et al., 1995). Vpu’s role in virus release, on the
bic amino acids at the N-terminus followed by a 54- other hand, is not specific to HIV-1 and the Vpu protein
amino-acid cytoplasmic domain, and it does not possess is capable of enhancing the release of unrelated virus
any discernible extracellular domain. The N-terminal hy- particles from the plasma membrane of infected cells
drophobic amino acids serve both as the ER targeting (Gottlinger et al., 1993).
signal and as the membrane anchor. Moreover, the cyto- Furthermore, the Vpu protein has been shown to be
plasmic domain of Vpu is phosphorylated by the ubiqui- localized predominantly in the perinuclear region of HIV-
tous casein kinase-2 (CK-2) at positions Ser52 and Ser56 1-infected cells (Klimkait et al., 1990) and is not present
(Schubert et al., 1994). in virus particles (Strebel et al., 1989; Terwilliger et al.,
CK-2 phosphorylation is critical in the induction of Vpu- 1989; Schwartz et al., 1990). However, this protein has
roles in at least two well-described reactions in mamma-
lian cells and these reactions occur in spatially sepa-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (216) 444-0512. E-mail: jabbara@cesmtp.ccf.org. rated cellular compartments (ER vs plasma membrane).
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Experiments with the phosphorylation mutants of Vpu 8. 5* CTTCTCCTTCATTCTCATTGCCATTGTCTTCTGCT
3*-vpP**-Bhave indicated that the CD4 proteolysis and virus release
functions of Vpu could occur in distinct compartments of
The primers A and D represent sequences (5* and 3*,the infected cell (Schubert and Strebel, 1994; Schubert
respectively) within the plasmid pcDNA1 and outside ofet al., 1996). However, the membrane topology of Vpu
the genes are cloned. Hybrid gene constructs and muta-(membrane–cytoplasmic domains only) has precluded
genesis were done according to the methods of Ho etattempts to decipher information about its membrane
al. (1989). Briefly, the primers (each 250 nM) were an-trafficking patterns in mammalian cells.
nealed to template DNA (100 ng) encoding Vpu or CD4 toIn this study, we present evidence that the Vpu protein
generate two DNA fragments (AB or CD) in PCR reactionstethered to the CD4 extracellular domain is capable of
using PFU polymerase (Strategene, San Diego, CA). Gel-trafficking to the plasma membrane and that the CD4
purified fragments were combined and fusion reactionsdomain appended to Vpu is present at the cell surface
were done using primers A and D. The fusion productsundergoing endo-H-resistant modifications in the Golgi
were gel purified and CD4/Vpu hybrid fragments werecomplex. Importantly, wt Vpu in the CD4/Vpu hybrid was
released after digestion with EcoRI and XbaI. All PCRbiologically active in inducing the degradation of HIV
reactions were performed in 25 to 30 cycles using aenvelope glycoproteins having Vpu-responsive se-
Thermal Cycler (Raja et al., 1993). The EcoRI–XbaI genequences. It is also shown here that CK-2 phosphorylation
fragments were cloned into pcDNA1 and sequenced us-of the Vpu cytoplasmic domain is critically important for
ing Sequanase. To introduce mutations in the CK-2 phos-the reconstitution of functional Vpu in the cell. Further-
phorylation sites in the Vpu gene fragment, pcDNCD4E-more, the Vpu transmembrane domain is capable of mod-
VpuF or pcDNCD4EA-VpuC were used as the templates.ulating the biological activity of Vpu, and the Vpu protein
Primers vpP**-C and vpP**-B were used in combinationrecognizes CD4 sequences in trans on the ER mem-
with primers A and D as AB and CD. The underlinedbranes before inducing the degradation of type I glyco-
bases in the mutation primers denote substitutions inproteins in the ER lumen.
Vpu gene sequences to generate the desired changes
(S to N) in the CD4/Vpu hybrid proteins.
MATERIALS AND METHODS
Transfection, radioimmunoprecipitation, and proteinCells, viruses, and expression plasmids
analyses
HeLa cells were used for the expression of Vpu and
Cells (5 1 105) were seeded onto 35-mm dishes 1 dayenvelope glycoproteins. The recombinant vaccinia virus
prior to transfection. The cells were infected with thevTF7-3 that synthesizes T7 RNA polymerase in infected
recombinant vaccinia virus vTF7-3 at m.o.i. 10 and appro-cells (Fuerst et al., 1987) was employed for expression
priate amounts of DNA and Lipofectin (GIBCO BRL) werestudies. The genes encoding envelope glycoproteins,
mixed and added to the cells (Raja et al., 1993). Pulse-Vpu, and CD4/Vpu hybrid proteins were cloned under
chase experiments of transfected cells were performedcontrol of the T7 promoter in the expression vector
at 16 hr posttransfection. The cells were starved for 1 hrpGem-3 (Promega, Madison, WI) or pcDNA1 (Invitrogen,
in medium lacking methionine, pulse-labeled with [35S]-San Diego, CA) as described (Vincent et al., 1993).
methionine (DuPont–NEN; 1000 Ci/mmol; 100 mCi/ml)
for 30 min, and chased in medium containing excessSite-directed mutagenesis and gene constructs
unlabeled amino acids and 2.5% serum. Cell lysates were
prepared in RIPA buffer, immunoprecipitated with spe-The following primers were used to generate CD4/Vpu
cific antibodies, and analyzed by SDS–PAGE as de-fusion proteins, as well as to introduce mutations in the
scribed previously (Vincent et al., 1993). The levels andCK-2 phosphorylation sites of Vpu sequences:
stability of proteins were quantified using a PhosphorIm-
1. 5* CATAACTTACGGTAAATGGC 3*-A ager (Molecular Dynamics, U.S.A.).
2. 5* TCTCTGTAGGTAGTTTGTCC 3*-D
3. 5* CACCCCGGTGCAGCCAATGCAACCTATAATAG- In vivo phosphorylation of CD4/Vpu hybrid proteins
TAGC 3*-cd4vp-FC
Plasmids encoding hybrid proteins were transfected4. 5* GCTACTATTATAGGTTGCATTGGCTGCACCGG-
into HeLa cells using Lipofectin as described previouslyGGTG 3*-cd4vp-FB
(Raja et al., 1993). At 16 hr posttransfection, the cells
5. 5* GGCATCTTCTTCTGTGTCGAATATAGGAAAATA- were washed in PBS and maintained for 90 min in MEM
TTAAG 3*-cd4vp-TC (GIBCO BRL) lacking sodium phosphate. Subsequently,
6. 5* CTTAATATTTTCCTATATTCGACACAGAAGAAG- the medium was removed and replaced with the same
ATGCC 3*-cd4vp-TB medium containing [32P]orthophosphate (DuPont–NEN,
200 mCi/ml) for 3 hr. After labeling, the cells were washed7. 5* AGCAGAAGACAATGGCAATGAGAATGAAGGA-
GAAG 3*-vpP**-C with PBS, lysed in RIPA, and immunoprecipitated with
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aVpu antibody (Vincent and Jabbar, 1995). To monitor the
expression levels of Vpu proteins, parallel cultures were
labeled with [35S]methionine (100 mCi/ml) and cell lysates
were immunoprecipitated as described above.
Indirect immunofluorescence
HeLa cells were seeded onto cover glasses and infec-
tion and transfection were performed as described
above. At 6 hr posttransfection, cells were fixed in 3.6%
paraformaldehyde for 10 min and stained with antibodies
to detect the surface expressing proteins or permeabil-
ized with 1% NP-40 to reveal internal antigens of
transfected cells. For analyzing Vpu proteins, aVpu anti-
body and FITC-conjugated secondary antibodies (anti-
rabbit) were added sequentially to the permeabilized
cells after thorough washing with PBS in each step. For
detecting CD4, aCD4 antibody and FITC-conjugated anti-
sheep antibodies were used. Fluorescing cells were
viewed under a Zeiss inverted microscope.
FIG. 1. Construction and schematics of CD4/Vpu hybrid proteins.Western blot and immunodetection of proteins
CD4 and Vpu sequences were amplified in PCR reactions using appro-
priate primers as described under Materials and Methods. The CD4Transfected cells were lysed in 50 ml of lysis buffer
and Vpu fragments had overhanging heterologous sequences compli-(50 mM Tris–HCl, pH 8.0, 100 mM NaCl, 1.0% NP-40,
mentary to Vpu and CD4 that facilitated the joining of the two se-
and 5 mM MgCl2) by repeated pipetting and the lysates quences in the fusion reaction. Recombinant clones were identified
were clarified after centrifugation at 14K for 10 min. The and sequenced to verify in frame fusion of CD4 and Vpu sequences
generating CD4/Vpu fusion proteins. Two fusion proteins (CD4E–VpuFproteins were quantified using Bio-Rad protein estima-
and CD4EA–VpuC), CD4, and Vpu are diagramatically shown.tion reagent. Protein samples (15 mg) were run in 10%
SDS–PAGE and transferred to nitrocellulose membrane
using the Bio-Rad semidry transfer system. The mem- fication, we generated four CD4/Vpu constructs: one hav-
branes were blocked in 5% milk in TBS / Tween 20 (10 ing the extracellular–transmembrane domains of CD4
mM Tris–HCl, pH 8.0, 50 mM NaCl, and 0.05% Tween and the Vpu cytoplasmic domain (CD4EA–VpuC) and the
20) for 1 hr at room temperature. For the detection of second having the extracellular domain of CD4 and the
envelope glycoproteins, HIV gp120 SF2 antibody was di- full-length Vpu protein (CD4E–VpuF). In addition, muta-
luted to 1:500 in 5% milk and the membranes were incu- tions were introduced in the CK-2 phosphorylation sites
bated in this for 2 hr at room temperature. The blots were of the hybrid proteins. The structures of Vpu, CD4, and
washed twice in TBS / Tween 20 and once in TBS for CD4/Vpu hybrid proteins are shown schematically in
15 min each. Peroxidase-conjugated anti-goat secondary Fig. 1.
antibody (Boehringer Mannheim) was diluted to 1:3000 The plasmids encoding CD4, CD4/Vpu, or Vpu proteins
in 5% milk and blots were incubated for 1 hr followed by were introduced into HeLa cells for expression analysis.
washings as described above. The proteins were de- Transfected cells were labeled separately with [35S]-
tected using enhanced chemiluminescence reactions methionine and [32P]orthophosphate, and detergent ly-
(ECL, Amersham) as per the manufacturer’s protocol. For sates were made for immunoprecipitation with aCD4 and
the detection of Vpu or CD4/Vpu chimeric proteins, the aVpu antibodies. Immunoprecipitates were analyzed on
blots were incubated in the stripping buffer (100 mM 12.5% PAGE–SDS (Fig. 2). CD4 synthesized in HeLa cells
BME, 2% SDS, and 62.5 mM Tris–HCl, pH 6.8) at 507C was not phosphorylated (lanes 1 and 8). This result was
for 30 min. HIV-1 Vpu antiserum (1:2000) and peroxidase- expected as CD4 lacks CK-2 consensus sites and is not
conjugated anti-rabbit antibody (1:2000) were used to a substrate for the ubiquitous CK-2. wtVpu, on the other
detect the proteins. hand, was phosphorylated (lanes 2 and 9), but a Vpu
gene having mutations in the phosphoacceptor sites
RESULTS (Ser52,56 to Asn52,56) expressed a protein that was not
phosphorylated (lanes 3 and 10). Importantly, the expres-Construction and expression of CD4/Vpu hybrid
sion of CD4E–VpuF and CD4EA–VpuC (lanes 4 and 6)proteins
in HeLa cells revealed that these proteins are phosphory-
lated (lanes 11 and 13). However, the CD4/Vpu proteinsPrimers were designed to join in-frame sequences that
encode full or parts of CD4 and Vpu proteins as de- (lanes 5 and 7) lacking the CK-2 sites CD4E–VpuFP and
CD4E–VpuCP were defective in phosphorylation (lanesscribed under Materials and Methods. Using PCR ampli-
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cells. This pattern indicated that the CD4/Vpu hybrid pro-
teins are delivered to the cell surface via the Golgi com-
plex.
As controls we expressed wtVpu and Vpu-P** and
stained them with aVpu antiserum. Both proteins showed
localization profiles indistinguishable from each other
and are mostly reticular in nature (Figs. 3J and 3L), sug-
gesting that they are in the ER network. The discrepancy
in intracellular staining of the cells expressing the Vpu
and CD4/Vpu hybrid could be due to differences in mem-
brane association properties of these proteins. Vpu asso-
ciates weakly with ER membranes and this could be due
to the absence of any discernible ectodomain in the Vpu
protein (Vincent and Jabbar, unpublished observations).
On the other hand, the CD4/Vpu hybrids were perhaps
stabilized by the CD4 extracellular domain exhibiting a
rather tight association with membranes and a finite
Golgi localization pattern in HeLa cells. More importantly,
the CD4/Vpu hybrid proteins are targeted to the plasma
membrane, as evidenced by cell surface staining by theFIG. 2. Expression and phosphorylation of CD4/Vpu fusion proteins.
Cells (5 1 105) expressing CD4/Vpu fusions and the Vpu protein were aCD4 antibody (Figs. 3D and 3G). Thus, the indirect im-
labeled with [35S]methionine (A) or [32P]orthophosphate (B) and lysed munofluorescence data have strongly suggested that
in RIPA. Detergent lysates were immunoprecipitated with CD4- and HIV-1 Vpu does not possess sequences that would se-
Vpu-specific antibodies before being analyzed on 12.5% PAGE–SDS.
quester the CD4 extracellular domain in the intracellular
compartments of HeLa cells.
12 and 14). We quantified the protein bands (32P and 35S)
and calculated the 32P to 35S ratio (data not shown). These Glycosidic modification and transport kinetics of CD4/
analyses revealed the CD4/Vpu proteins (CD4E–VpuF Vpu proteins in the secretory pathway
and CD4E–VpuC) were phosphorylated as efficiently as
The acquisition of endo-H resistance by proteins traf-wtVpu by CK-2 in HeLa cells.
ficking through the secretory pathway has been exten-
sively used to probe the movement of proteins in mam-Cellular localization of Vpu and CD4–Vpu proteins in
malian cells (Doms et al., 1993; Rothman and Orci, 1992).HeLa cells
We have previously shown that CD4 is delivered to the
cell surface undergoing the endo-H modification in theThe Vpu protein consists mostly of the transmem-
brane/cytoplasmic domain with little or no extracellular Golgi complex (Jabbar and Nayak, 1990; Raja et al., 1993).
As shown in Fig. 3, the CD4/Vpu hybrid proteins aredomain. This membrane topology has only limited ac-
cess to antibody probes for the elucidation of membrane present at the cell surface as evidenced by staining of
the CD4 extracellular domain by anti-CD4 antibody. Wetrafficking and cellular localization of the Vpu protein in
mammalian cells. Using Vpu cytoplasmic domain-spe- used a pulse-chase protocol to analyze the glycosidic
modification kinetics of CD4–Vpu hybrid proteins.cific antibodies, previous studies have demonstrated that
Vpu is localized in the intracellular compartments of HIV- Transfected cells were pulse-labeled with [35S]-
methionine for 30 min and chased in the presence ofinfected cells (Klimkait et al., 1990). In the present study,
we have appended the CD4 extracellular domain to the excess amounts of unlabeled amino acids for the indi-
cated times. 35S-labeled proteins were immunoprecipi-Vpu protein generating hybrid proteins and these pro-
teins were expressed in HeLa cells (Fig. 2). To examine tated by aVpu antibody. One half of the immunoprecipi-
tate was treated with endo-H and the other half was leftthe intracellular localization of CD4/Vpu hybrid proteins,
we performed an indirect immunofluorescence assay as untreated (Fig. 4). The proteins made during the 30-min
pulse were sensitive to endo-H, indicating their ER resi-described (Raja et al., 1993). Transfected cells were
stained with CD4 and Vpu-specific antibodies and the dence with high-mannose sugar modifications (lanes 1
and 2). During the chase time, however, all four hybridproteins were probed for their cellular location in HeLa
cells. aCD4 antibodies labeled both the intracellular and proteins began to show resistance to endo-H (lanes 3–
12), indicating their movement through the Golgi complexthe cell surface forms of CD4 and CD4/Vpu hybrid pro-
teins (Figs. 3A, 3B, 3D, 3E, 3G, and 3H). Intracellular for delivery on the cell surface. Furthermore, the kinetics
of endo-H resistance revealed that the CD4–Vpu hybridstaining of the cells expressing hybrid proteins with aVpu
(Figs. 3F and 3I) and aCD4 (Figs. 3E and 3H) showed proteins traversed the secretory pathway with equal effi-
ciency. Note, however, that all the hybrid proteins ac-that they were present in the perinuclear region of HeLa
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FIG. 3. Localization of CD4/Vpu and Vpu proteins in HeLa cells. Transfected cells were fixed with 3.6% formaldehyde for 10 min at room temperature
and fixed cells were labeled with appropriate antibodies to reveal the presence of proteins at the plasma membrane as described (surface proteins,
A, D, and G). For the detection of internal proteins, fixed cells were permeabilized with 1% NP-40 (B, C, E, F, and H–L). (A-C) CD4; (D–F) CD4E–
VpuF; (G–I) CD4EA–VpuC; (J– L) Vpu. Proteins were stained with either anti-CD4 antibody (A, B, D, E, G, H, and K) or anti-Vpu antibody (C, F, I, J,
and L). The localization of wt (J) and unphosphorylated Vpu (L) was monitored using aVpu antibody as described under Materials and Methods.
quired only partial endo-H resistance and this correlates volving E-TC25 and CD4E-VpuF and followed a pulse-
chase protocol as above. Detergent-solubilized, [35S]-well with the modification kinetics of wtCD4 (Crise et al.,
methionine-labeled cell lysates were immunoprecipi-1990; Jabbar and Nayak, 1990). Thus, these experiments
tated with aVpu antiserum before being analyzed on 10%have demonstrated that the Vpu protein does not pos-
PAGE–SDS (Figs. 5 and 6). Figure 5A shows the expres-sess any sequence information that has the ability to
sion and formation of complexes between E-TC25 andsequester the CD4 extracellular domain in the intracellu-
CD4E-VpuF. During a 30-min pulse period, the Vpu anti-lar compartments of HeLa cells and that CK-2 phosphory-
serum precipitated two proteins with relative molecularlation does not play a role in the intracellular transport
mass corresponding to E-TC25 (arrowhead a) andof CD4/Vpu hybrid proteins.
CD4E–VpuF (arrowhead b). After 1 hr of chase, the
amount of E-TC25 in the complex had increased (lane 2)The Vpu protein appended to the CD4 extracellular
relative to its 30-min pulse level (lane 1). This presumablydomain (CD4E–VpuF) is biologically active in the
reflects the time it takes to acquire CD4 binding compe-secretory pathway
tence (Crise et al., 1990; Raja et al., 1993). Up to 3 hr
Using gp160/CD4 hybrid proteins, we previously postsynthesis (lanes 2–4), the amount of E-TC25 in the
mapped the Vpu-responsive elements in the transmem- complex remained relatively constant and had decreased
brane and cytoplasmic domains of CD4 (Vincent et al., precipitously after 4 hr of chase (lanes 5 and 6). However,
1993; Raja et al., 1994; Jabbar, 1995). One of the envelope the relative amounts of CD4E–VpuF in the complex were
glycoproteins, E-TC25, has the ER retention signal (KKTC) unchanged during the pulse and throughout chase times
and underwent degradation in cells expressing Vpu (Raja (arrowhead b, lanes 1–6), suggesting that CD4E–VpuF
et al., 1994; Vincent and Jabbar, 1995). To examine was stable in the complex during the 5-hr chase period.
whether the Vpu protein appended to the CD4 extracellu- It should be noted here that the recovery of low amounts
lar domain was active in inducing the degradation of of E-TC25 was not due to inefficient or altered binding
to CD4E–VpuF at later time points, as second rounds ofE-TC25, we performed cotransfection experiments in-
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port through the secretory pathway. Importantly, the
amount of E-TC25 in the complex remained constant
throughout the chase period, indicating that unlike
CD4E–VpuF, CD4E–VpuFP was not able to induce the
degradation of E-TC25. Thus, these experiments have
demonstrated that CK-2 phosphorylation of CD4E–VpuF
is critically important to reconstitute Vpu-induced degra-
dation activity in the cell.
CD4E–VpuF-mediated proteolysis is dependent on
the presence of Vpu-responsive elements in gp160/
CD4 hybrid proteins
Our previous deletion analysis of a Vpu-sensitive enve-
lope glycoprotein, E-TC38, revealed that a 6-aa region in
the CD4 (LSEKKT) was critical in the Vpu-induced degra-
dation reaction (Vincent et al., 1993). Further studies have
demonstrated the importance of the CD4 transmembrane
FIG. 4. Intracellular transport and glycosylation of CD4/Vpu proteins domain as being one of the critical Vpu-responsive deter-
in HeLa cells. Transfected cells expressing the fusion proteins were minants (Raja et al., 1994). To examine whether CD4E–
pulse-labeled with [35S]methionine for 30 min and chased at the indi- VpuF induced the degradation of E-TC25 in a sequence-
cated times in the presence of unlabeled amino acids in medium con-
specific manner, we made use of two gp160/CD4 hybridtaining 2.5% serum. Detergent lysates were made and immunoprecipi-
tated with aVpu antibody. The immunoprecipitated proteins were di-
vided into two portions: to one added 5 U of endo-H (/) and the other
was left untreated (0). Samples were incubated overnight at 377 and
analyzed in 10% SDS–PAGE.
immunoprecipitation did not reveal free E-TC25 in deter-
gent lysates (data not shown). Furthermore, we could not
detect E-TC25–CD4E–VpuF complexes using agp120
(gp120-specific) or OKT4A (CD4-specific), indicating that
E-TC25 is bound tightly to CD4E–VpuF, masking both
gp120 and CD4 binding sites in the complex (Jabbar and
Nayak, 1990). Thus these experiments demonstrated that
the Vpu protein tethered to the CD4 extracellular domain
was active in inducing the degradation of a Vpu-sensitive
glycoprotein, E-TC25.
CK-2 phosphorylation is critical for the biological
activity of CD4E–VpuF
We and others have demonstrated that CK-2 phosphor-
ylation is critical for the sequence-specific degradation
of Vpu-sensitive proteins in the ER (Schubert and Strebel,
1994; Vincent and Jabbar, 1995). To examine the role of
CK-2 phosphorylation in the CD4–VpuF-mediated degra-
dation of E-TC25, we transfected cells with plasmids en-
coding E-TC25 and CD4E–VpuFP and performed pulse-
FIG. 5. CD4E–VpuF induces the degradation of E-TC25 and it ischase experiments. 35S-labeled detergent lysates pre-
phosphorylation dependent. (A) Plasmids encoding E-TC25 (3 mg) andpared from transfected cells were immunoprecipitated
CD4E–VpuF (6 mg) were transfected into HeLa cells (5 1 105).
with aVpu antiserum and proteins were analyzed on 10% Transfected cells were pulse-labeled for 30 min with [35S]methionine
PAGE–SDS (Fig. 5A, lanes 7–12). During the 30-min (100 mCi/ml) and chased at the indicated times in medium containing
unlabeled amino acids and 2.5% serum. The cells were lysed in RIPApulse period, two prominent protein bands were identi-
and protein complexes were immunoprecipitated with aVpu antibodyfied in aVpu immunoprecipitates and they represented
before being analyzed on 10% PAGE–SDS. (B) CD4E–VpuF-mediatedE-TC25 (arrowhead a) and CD4E–VpuFP (arrowhead b).
degradation is sequence specific. The plasmids encoding E-TC18 and
After 1 hr of chase, the proportion of E-TC25 in the com- EA-C25 were transfected into cells in the presence of plasmids that
plex had increased, reflecting the assembly and associa- expresses CD4E–VpuF. Pulse-chase experiments and immunoprecipi-
tations were done as described for A.tion properties of E-TC25 and CD4E–VpuFP during trans-
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AC25, and CD4E–VpuF. The results of the analysis are
shown in Fig. 5B. Both E-TC18 (arrowhead a, lanes 1–
6) and EA-C25 (arrowhead a, lanes 7–12) were stable
in complexes with CD4E–VpuF. Thus, these experiments
have indicated that CD4E–VpuF could not induce the
degradation of glycoproteins which lacked Vpu-respon-
sive sequences in either the transmembrane domain (E-
AC25) or the cytoplasmic domain (E-TC18).
Role of the Vpu transmembrane domain in E-TC25
degradation
Our previous experimental evidence is highly sugges-
tive of the importance of the CD4 transmembrane domain
in the initial recognition of Vpu and CD4 sequences in
the ER membrane (Raja et al., 1994). Implicit in that pro-
posal is that the Vpu transmembrane domain could play
a critical role in the recognition process. In the present
study, we made a hybrid protein having the extracellular–
transmembrane domains of CD4 and the Vpu cyto-
plasmic domain (CD4EA–VpuC). A mutant version of
CD4EA–VpuC lacking the CK-2 phosphorylation sites
was also generated (CD4EA–VpuCP). We performed co-
transfection experiments involving the three gp160/CD4
hybrid proteins, E-TC25, E-TC18, and E-AC25, and the
two CD4/Vpu proteins, CD4EA-VpuC and CD4EA-VpuCP.
Complexes were precipitated with aVpu antiserum from
cell lysates of coexpressing cells (Figs. 6A and 6B). We
quantified protein bands and calculated the ratios of the
gp160/CD4 to CD4/Vpu proteins in the complexes (Fig.
6C). The amount of E-TC25 was significantly reduced in
CD4EA–VpuC–E-TC25 complexes (Fig. 6A, lanes 1–5)
as opposed to that in other coexpression conditions (Fig.
6A, lanes 7–12, and Fig. 6B, lanes 1–12). Note that E-
TC25 was highly unstable in cells expressing CD4E–
VpuF and this was due to the activity of full-length Vpu
in the hybrid protein CD4E–VpuF. By contrast, E-TC25
exhibited intermediate stability profiles (Fig. 6A, lanes 1–
6, and Fig. 6C, line C). These experiments have strongly
suggested that the Vpu transmembrane domain plays a
role in the degradation of a Vpu-sensitive glycoprotein,
E-TC25, and this property of the domain was revealed
under the conditions of complex formation between E-FIG. 6. The Vpu transmembrane has a role in inducing the degrada-
tion of E-TC25. CD4EA–VpuC or CD4EA–VpuCP was expressed either TC25 and CD4EA–VpuC. Furthermore, E-TC25 was
with E-TC25 (A) or E-TC18 and EA-C25 (B). Pulse-chase analyses, lysis highly stable in cells expressing CD4EA–VpuCP (Fig. 6A,
of labeled cells, and immunoprecipitation of protein complexes with lanes 7–12, and Fig. 6C, line D) and this is consistent
aVpu antibody were the same as described for Fig. 5A. (C) Quantitation
with a predominant role of CK-2 phosphorylation in Vpu-of protein bands [data obtained from Fig. 5A (lanes 1–12) and Fig. 6A
mediated degradation reactions in the ER.(lanes 1–12)] was done in a PhosphorImager and the ratios of E-TC25
to CD4–Vpu hybrid proteins (A. CD4E-VpuF; B. CD4E-VpuFP; C. CD4EA-
VpuC; D. CD4EA-VpuCP) were calculated using the relative quantitative CD4E–VpuF and wtVpu reduce the steady-state
values of individual hybrid proteins in the complexes. levels of E-TC25
We noticed that the amount of E-TC25 was lower dur-
ing the pulse and chase times in cells expressing CD4E–proteins, E-TC18 and EA-C25. Previously we had shown
that E-TC18 and EA-C25 lacked sequences that are re- VpuF and E-TC25 (Fig. 5A, lanes 1–6) as opposed to the
situation in coexpression of Vpu and E-TC38 (Vincent etsponsive to Vpu and were stable in the presence of
wtVpu (Vincent et al., 1993; Raja et al., 1994). We therefore al., 1993; Raja et al., 1994). As shown above, this reduced
amount was not due to the inability of the CD4E–VpuFperformed pulse-chase experiments involving E-TC18, E-
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protein to bind the precursor protein in the ER. Therefore
these pulse-chase experiments suggested that the
amount of precursor proteins was rather low at the time
of labeling and consequently low levels of E-TC25 were
present in the CD4–Vpu–E-TC25 complex. Previous ex-
periments have demonstrated that the expression of
wtVpu reduces the recovery of CD4 in immunoprecipi-
tates and this was due to a reduction in the steady-state
levels of CD4 in cells expressing wtVpu (Willey et al.,
1992b; Vincent et al., 1993; Lenburg and Landau, 1993).
We therefore examined the expression levels of E-TC25
in the presence of wtVpu and CD4E–VpuF in cell extracts
using Western blots. Detergent lysates were run on
SDS–PAGE and proteins were transferred to nitrocellu-
lose membranes before being probed with specific anti-
bodies as described under Materials and Methods. We
also used phosphorylation-deficient mutants of Vpu (Vpu-
P**) and CD4E–VpuF (CD4E–VpuFP) to analyze the ef-
fects of CK-2 phosphorylation in steady-state levels. Fig-
ures 7A and 7B show the expression levels of proteins
made in single and coexpressing HeLa cells. In single
and coexpression conditions, the Vpu and CD4–Vpu pro-
teins were made in equivalent amounts (Fig. 7A, lanes
1–4, and Fig. 7B, lanes 6 –10). In contrast, the expression
levels of E-TC25 were very much reduced in cells ex-
pressing wtVpu (Fig. 7B, lane 2) and CD4E–VpuF (Fig.
7B, lane 4). However, an equivalent amount of the precur-
FIG. 7. CD4E–VpuF reduces the steady-state level of E-TC25. Plas-sor E-TC25 was present in cells expressing E-TC25 alone
mids expressing wtVpu, Vpu-P**, CD4E-VpuF, and CD4E-VpuFP were
(Fig. 7B, lane 1) or in the presence of phosphorylation either singly transfected (A) or cotransfected with E-TC25 (B). Cells
mutants (Fig. 7B, lanes 3 and 5). Thus these experiments were lysed and 15 mg of the total protein was loaded into each well
in 10% SDS–PAGE. After the proteins were transferred to nitrocellulosehave revealed that wtVpu and the Vpu protein tethered
membrane, Vpu and CD4E–VpuF were detected with aVpu antibodyto CD4 are biologically active in reducing the steady-
(A, lanes 1–4). Lysates from the coexpressing cells were run in 10%state levels of E-TC25. Further, this activity is dependent
SDS–PAGE and the level of E-TC25 was probed with gp120SF2 anti-on the phosphorylation status of the Vpu cytoplasmic body (B, lanes 1–5). The same blot was stripped off and Vpu or CD4/
domain in both proteins. Vpu fusion proteins were detected with aVpu antibody (B, lanes 6–10)
as described under Materials and Methods.We also analyzed whether this activity of Vpu requires
the Vpu-responsive element (VRE) in the cytoplasmic do-
main of CD4. To address this question, we made use of
bility of Vpu-sensitive proteins in the secretory pathway
an HIV gp160–CD4 hybrid protein, E-TC18, that lacks the
of mammalian cells.
VRE (Vincent et al., 1993), as well as other two glycopro-
teins that do not undergo degradation in cells expressing
DISCUSSION
Vpu (Vincent et al., 1993; Vincent and Jabbar, 1995). West-
ern blot analysis of the HIV proteins in the absence and In this report, we presented evidence that the Vpu
protein tethered to the CD4 extracellular domain waspresence of Vpu constructs is shown in Fig. 8. It is clear
that E-TC18, gp120, and gp160 were stable in cells ex- capable of trafficking to the plasma membrane. Previous
indirect immunofluorescence studies showed that Vpupressing wtVpu and CD4E–VpuF (Fig. 8A, lanes 1–9).
Comparable levels of the Vpu and CD4/Vpu proteins was localized predominantly in the intracellular compart-
ments of HIV-infected cells (Klimkait et al., 1990). Thesewere made in coexpressing cells (Fig. 8B, lanes 2, 3, 5,
6, 8, and 9). As expected no Vpu proteins were detected analyses were performed using antibodies specific to
the Vpu cytoplasmic domain. Tethering of the CD4 extra-in cells expressing the HIV proteins alone (Fig. 8B, lanes
1, 4, and 7). Thus these experiments have clearly demon- cellular domain to Vpu has provided us with an opportu-
nity to examine the presentation of CD4/Vpu hybrid pro-strated that functional Vpu does not affect the steady-
state levels of HIV proteins that lack the VRE (E-TC18, teins in the plasma membrane. In addition to demonstra-
ting the presence of CD4–Vpu proteins at the cell surfacegp120, and gp160). Taken together, these experiments
have demonstrated that the Vpu protein appended to the using indirect immunofluorescence, we analyzed the
transport kinetics of these hybrid proteins in the secre-CD4 ectodomain and wtVpu behave very similarly in all
aspects of the Vpu-induced effects that relate to the sta- tory pathway of HeLa cells. CD4 has two N-linked glyco-
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2 phosphorylation occurs in the Vpu cytoplasmic do-
mains of both CD4E–VpuF and CD4EA–VpuC. These
results further indicated that the Vpu cytoplasmic domain
tethered to the CD4 extracellular domain was accessible
to the ubiquitous casein kinase 2 in the cytosol similar to
that of sequences in wtVpu. Thus, the CD4 extracellular
domain does not appear to alter the conformational sta-
tus (at least related to CK-2 phosphorylation) of the Vpu
cytoplasmic domain.
Importantly, the hybrid protein CD4E–VpuF having the
Vpu protein at the C-terminus as its transmembrane and
cytoplasmic domains was able to induce the degradation
of a Vpu-sensitive envelope glycoprotein, E-TC25. This
degradation reaction occurred under the condition in
which CD4E–VpuF binds tightly to E-TC25, forming com-
plexes in the ER. We further showed that the CD4E–
VpuF-mediated degradation of E-TC25 was highly spe-
cific, requiring CK-2 phosphorylation of the Vpu cyto-
plasmic domain, as well as the Vpu-responsive elements
in the transmembrane and cytoplasmic domains of CD4
in E-TC25. The fact that CD4E–VpuF did not undergo
degradation in E-TC25–CD4–VpuF complexes strongly
suggests that the CD4 extracellular domain appended to
Vpu is resistant to any deleterious effects of Vpu activity
FIG. 8. wtVpu and CD4E–VpuF expression does not reduce the
in the ER lumen. Furthermore, a hybrid protein bearingsteady-state levels of proteins lacking the Vpu responsive sequence.
the CD4 extracellular/transmembrane domains and theE-TC18, gp160, and gp120 were either singly expressed or coex-
pressed with wtVpu or CD4E-VpuF in HeLa cells. Lysates were run in Vpu cytoplasmic domain (CD4EA–VpuC) was only par-
10% SDS–PAGE and proteins were transferred to nitrocellulose mem- tially active in inducing the proteolysis of E-TC25. This
brane. Envelope glycoproteins were detected using gp120SF2 antibody experiment suggested that the Vpu transmembrane do-
(A) and Vpu or CD4E–VpuF was detected with aVpu antibody (B) as
main plays a role in the reconstitution of active Vpu indescribed under Materials and Methods.
the ER membrane.
Previous experiments have shown that wtVpu induces
a reduction in the steady-state levels of CD4 (Willey etsylation sites that are modified by both ER and Golgi
glycosidic enzymes (Crise et al., 1990; Jabbar and Nayak, al., 1992b; Vincent et al., 1993; Lenburg and Landau,
1993) and remarkably, CD4E–VpuF exhibits a property1990). The CD4 extracellular domain appended to the
Vpu protein acquired endo-H resistance with kinetics similar to that of wtVpu in reducing the expression levels
of E-TC25 in transfected HeLa cells. This Vpu effect de-similar to that of wtCD4. This property of CD4–Vpu hybrid
proteins is strongly suggestive of the notion that the Vpu pends not only on the phosphorylation state of the Vpu
cytoplasmic domain, but also the presence of Vpu-re-protein does not possess any sequence information that
has the ability to sequester the CD4 extracellular domain sponsive sequences in gp160/CD4 hybrid proteins. Thus,
these studies have revealed that Vpu expression hasin the intracellular compartments of HeLa cells.
Furthermore, the possibility of the CD4 extracellular specific effects on the biogenesis of proteins bearing
CD4 sequences that respond to Vpu in the ER membrane.domain conferring plasma membrane localization to the
Vpu protein is highly unlikely for the following reasons. The evidence that Vpu sequences (in the context of
the CD4 extracellular domain) could be localized to theFirst, CD4 is transported to the cell surface through the
constitutive secretory pathway and does not possess a plasma membrane has implications in terms of under-
standing the potential role of Vpu in virus assembly/re-targeting signal(s) of its own (Rothman and Orci, 1992;
Rothman, 1994). Second, the CD4 extracellular domain lease processes. So far, it has been shown that Vpu has
roles in two well-described reactions: CD4 proteolysishas been extensively used to probe the compartment-
specific targeting signals of ER/Golgi localized proteins and virus release (Willey et al., 1992a,b; Yao et al., 1992;
Gieraghty and Panganiban, 1993; Vincent et al., 1993;in mammalian cells (Buonocore and Rose, 1990; Taka-
hashi et al., 1995; Jackson et al., 1993; Raja et al., 1993). Gottliger et al., 1993; Lenburg and Landau, 1993; Bour et
al., 1995b; Jabbar, 1995). These reactions occur in distinctTherefore, the cell surface expression and endo-H-resis-
tant properties of CD4–Vpu hybrids are highly indicative cellular compartments (Schubert and Strebel, 1994; Jab-
bar, 1995; Schubert et al., 1996): the ER (CD4 proteolysis)of the Vpu protein trafficking to the plasma membrane.
Our studies have also demonstrated that the CD4 extra- and the plasma membrane (enhancement of virus re-
lease). It is interesting to note that Vpu is coordinatelycellular domain did not affect the efficiency by which CK-
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virus type 1 Vpu has a CD4 and an envelope glycoprotein-indepen-synthesized with the envelope glycoprotein precursor
dent function. J. Virol. 67, 4190–4194.gp160 at equimolar amounts in HIV-infected cells
Gottlinger, H. G., Dorfman, T., Cohen, E. A., and Haseltine, W. A. (1993).
(Schwartz et al., 1990). The gp120/gp41 complex derived Vpu protein of human immunodeficiency virus type 1 enhances the
from gp160 is incorporated into budding virions to gener- release of capsids produced by gag gene constructs of widely diver-
gent retroviruses. Proc. Natl. Acad. Sci. USA 90, 7381–7385.ate infectious particles from the plasma membrane, but
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R.the Vpu protein is not part of the virion (Klimkait et al.,
(1989). Site-directed mutagenesis by overlap extension using the1990; Terwilliger et al., 1989). We can envisage a few
polymerase chain reaction. Gene 77, 51–59.
scenarios for the apparent lack of Vpu incorporation into Hunter, E. (1994). Molecular interactions in the assembly of HIV and
virus particles. (1) The Vpu protein is sorted to a cellular other retroviruses. Semin. Virol. 5, 71–86.
Jabbar, M. A. (1995). The human immunodeficiency virus type 1 Vpulocation from where it could not access the HIV assembly
protein: Roles in virus release and CD4 down-modulation. Curr. Top.complex. (2) Vpu consists mostly of transmembrane and
Microbiol. Immunol. 193, 107–120.cytoplasmic domains and this membrane topology could
Jabbar, M. A., and Nayak, D. P. (1990). Intracellular interaction of human
somehow prevent it from interacting with the machinery immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160
that assembles infectious particles at the plasma mem- with CD4 blocks the movement and maturation of CD4 to the plasma
membrane. J. Virol. 64, 6297–6304.brane (Hunter, 1994). Future experiments with CD4/Vpu
Jackson, M. R., Nilsson, T., and Peterson, P. A. (1993). Retrieval ofhybrid proteins have the potential of deciphering the
transmembrane proteins to the endoplasmic reticulum. J. Cell Biol.mechanisms of CD4 proteolysis and virus release in the
121, 317–333.
endomembrane compartments of mammalian cells. Klimkait, T., Strebel, K., Hoggan, M. D., Martin, M. A., and Orenstein,
J. M. (1990). The human immunodeficiency virus type 1-specific pro-
tein vpu is required for efficient virus maturation and release. J. Virol.ACKNOWLEDGMENTS
64, 621–629.
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